Compare STXS & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STXS | WALD |
|---|---|---|
| Founded | 1990 | 1988 |
| Country | United States | United Kingdom |
| Employees | N/A | 364 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.3M | 179.6M |
| IPO Year | 2004 | N/A |
| Metric | STXS | WALD |
|---|---|---|
| Price | $1.89 | $1.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $4.00 | $2.00 |
| AVG Volume (30 Days) | 364.7K | ★ 1.3M |
| Earning Date | 05-12-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $29,346,617.00 | N/A |
| Revenue This Year | $28.22 | $9.89 |
| Revenue Next Year | $30.47 | $4.31 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.74 | $0.72 |
| 52 Week High | $3.59 | $3.22 |
| Indicator | STXS | WALD |
|---|---|---|
| Relative Strength Index (RSI) | 47.78 | 64.53 |
| Support Level | $1.75 | $1.52 |
| Resistance Level | $1.99 | $1.63 |
| Average True Range (ATR) | 0.10 | 0.19 |
| MACD | 0.00 | 0.08 |
| Stochastic Oscillator | 54.17 | 76.61 |
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.